. 2002 Mar;46(3):841–847. doi: 10.1128/AAC.46.3.841-847.2002

TABLE 5.

Prophylactic efficacy of RFI-641 after intranasal administration (6 mg) at 2 h preinfection in African green monkeys

Day	Log₁₀ titer reduction in samples from:
Day	Nasal passage	Throat	BAL fluid
3	0.2	0.43
4	1.87^a	0.7	0.39
6	2.32^a	1.81^a	1.99^a
7	2.26^a	1.75^a
8	3.38^a	1.4^a	1.56^a
9	3.33^a	1.39
10	1.46	2.17^a

Significant by Fisher's least significant difference comparison at a P value of <0.05.